First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics Inc
- Market cap
- $1.87B
Your view on TRAX
Overview
What the company does, where it operates, and who runs it.
About First Tracks Biotherapeutics Inc
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Daniel R. Faga
- Headquarters
- 10770 Wateridge Circle, San Diego, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Daniel R. Faga
- Headquarters
- 10770 Wateridge Circle, San Diego, CA, US
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments.
The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for First Tracks Biotherapeutics Inc. Starting points for First Tracks Biotherapeutics Inc: EPS -$4.41, beta 3.37 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for First Tracks Biotherapeutics Inc. Trailing twelve-month EPS for First Tracks Biotherapeutics Inc stands at -$4.41. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
10 firms, last 12 months- Strong Buy0
- Buy10
- Hold0
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.73 | −$0.76 | −$3.99 | −$3.46 |
| Lowest estimate | −$0.81 | −$0.88 | −$4.03 | −$3.93 |
| Highest estimate | −$0.67 | −$0.63 | −$3.97 | −$2.69 |
| Number of analysts | 6 | 4 | 6 | 7 |
| A year ago | — | −$1.45 | $0.001 | — |
| Growth vs a year ago | — | +47.4% | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $0.00 | $0.00 | $75.00M | $0.00 |
| Lowest estimate | $0.00 | $0.00 | $75.00M | $0.00 |
| Highest estimate | $0.00 | $0.00 | $75.00M | $0.00 |
| Number of analysts | 0 | 0 | 4 | 0 |
| A year ago | — | $0.00 | $0.00 | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for First Tracks Biotherapeutics Inc. First Tracks Biotherapeutics Inc has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| ACRSAclaris Therapeutics, Inc. | Healthcare | Biotechnology | $555.1M | ||
| ANABAnaptysBio, Inc. | Healthcare | Biotechnology | $1.4B | ||
| CLYMClimb Bio, Inc. | Healthcare | Biotechnology | $546.3M | ||
| ELDNEledon Pharmaceuticals, Inc. | Healthcare | Biotechnology | $171.5M | ||
| IMUXImmunic, Inc. | Healthcare | Biotechnology | $102.6M | ||
| IMVTImmunovant, Inc. | Healthcare | Biotechnology | $6.9B | ||
| MLTXMoonLake Immunotherapeutics | Healthcare | Biotechnology | $918.3M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PHARPharming Group N.V. | Healthcare | NASDAQ | $882.4M | ||
| PHATPhathom Pharmaceuticals, Inc. | Healthcare | NASDAQ | $430.8M | ||
| PHGUFPharming Group N.V. | Healthcare | OTC | $1.1B | ||
| PHIOPhio Pharmaceuticals Corp. | Healthcare | NASDAQ | $8.6M | ||
| PHMMFPharma Mar, S.A. | Healthcare | OTC | $1.5B | ||
| PHRM.CNPharmaTher Holdings Ltd. | Healthcare | CNQ | $9.1M | ||
| PHRRFPharmaTher Holdings Ltd. | Healthcare | OTC | $5.3M | ||
| PHVSPharvaris N.V. | Healthcare | NASDAQ | $2.2B | ||
| PHYOFIXICO plc | Healthcare | OTC | $6.5M | ||
| PKTXProtoKinetix, Incorporated | Healthcare | OTC | $2.7M | ||
| PLRXPliant Therapeutics, Inc. | Healthcare | NASDAQ | $41.0M | ||
| PLRZPolyrizon Ltd. | Healthcare | NASDAQ | $12.4M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | $689.2B in assets | 0.00% | |
| XBIState Street SPDR S&P Biotech ETF | $10.0B in assets | 0.41% | |
| IWMiShares Russell 2000 ETF | $76.6B in assets | 0.05% | |
| VXFVanguard Extended Market ETF | $30.2B in assets | 0.02% | |
| BBCVirtus LifeSci Biotech Clinical Trials ETF | $32M in assets | 2.12% | |
| OMFSInvesco Russell 2000 Dynamic Multifactor ETF | $267M in assets | 0.63% | |
| VTWGVanguard Russell 2000 Growth ETF | $1.4B in assets | 0.07% | |
| RSSLGlobal X - Russell 2000 ETF | $1.4B in assets | 0.05% | |
Largest holders first, then the funds most concentrated in TRAX.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold First Tracks Biotherapeutics Inc, and how their positions are changing. At a $1.87B market value, institutional positions materially move First Tracks Biotherapeutics Inc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by First Tracks Biotherapeutics Inc executives and directors. Shares of First Tracks Biotherapeutics Inc have traded between $14.72 and $48.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for First Tracks Biotherapeutics Inc. Coverage tracks First Tracks Biotherapeutics Inc within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of First Tracks Biotherapeutics Inc.